Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-24-005079

Options or other derivatives

  • CFO returned 0 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Raines Heather CFO 2024-02-02 Returned to the company · 8% Unsecured Convertible Promissory Note due 2022 −0 $25,000.00 $0 D
Loading xslF345X05/ownership.xml…